Personal genetics company seeks regulatory approval
Monya Baker, nature.com
Personal genetics company 23andMe announced Monday that it was seeking FDA approval for an initial batch of seven health-related tests with scores more to follow.
23andMe, based in Mountain View, California, markets genetics test…
Related articles
- 23andMe’s Tools Help Solve Ancestry Mystery (23andme.com)
- One Million Strong, A Note from 23andMe’s Anne Wojcicki (23andme.com)
- 23andMe Requests FDA Clearance for DNA Saliva Testing (labsoftnews.typepad.com)
- Check Out The Geekiest Black Friday Deal Ever (GOOG) (embargozone.com)
- 23andMe Sets Growth Goal Of One Million Customers, Reduces Price to $99 (quantifiedself.com)
- Russian billionaire backs 23andMe in $50M round (fiercebiotechit.com)
- 23andMe Raises More Than $50M From Milner, NEA, Brin, Google, Others (pehub.com)
- Genetics startup 23andMe raises $50M from Yuri Milner & others, drops price to $99 (venturebeat.com)
- 23andMe and Genentech Expand Cancer Study (23andme.com)
- Decoding Your DNA: Does First Class and Economy Already Exist? (raventools.com)
You must be logged in to post a comment.